Microtissue technology has tremendous advantages for screening of biochemical compounds. Due to the higher level of functionality and biomimicry, screens using microtissues show a significantly higher biological relevance than standard cellular monolayers.

InSphero offer for the first time commercial ready-to-use microtissues, microtissue assays and a 3D cell-culture solution, which integrates seamlessly with existing laboratory liquid-handling robotics and provides a production capacity of >10’000 microtissues per day and line. The cost is in the range of standard monolayer cultures.